Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
Longterm Followup Finds Taxotere Improves Survival
Drug Combination Tested For B.C. Brain Metastases
Sunitinib May Be Associated With Cardiac Toxicity
BRCA Carriers Live Longer Than Those With Normal Gene
Rev/Vel/Dex Response Rate High In Phase I/II Study
FDA Approves Genetic Test For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer - Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science
- The defining question of the next decade is not how many drug candidates can be generated, but who decides which ones move forward, and why
Drug development must convene a forum for candid, cross-sector discussion
